These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2478431)

  • 21. Bacterial lysate for the prevention of chronic rhinosinusitis recurrence in children.
    Chen J; Zhou Y; Nie J; Wang Y; Zhang L; Shi Q; Tan H; Kong W
    J Laryngol Otol; 2017 Jun; 131(6):523-528. PubMed ID: 28318451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive value of nasal bacterial culture for etiological agents in acute maxillary sinusitis.
    Savolainen S; Ylikoski J; Jousimes-Somer H
    Rhinology; 1987 Mar; 25(1):49-55. PubMed ID: 3554464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriology of chronic maxillary sinusitis and normal maxillary sinuses: using culture and multiplex polymerase chain reaction.
    Kalcioglu MT; Durmaz B; Aktas E; Ozturan O; Durmaz R
    Am J Rhinol; 2003; 17(3):143-7. PubMed ID: 12862402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intranasal vaccines for protection against respiratory and systemic bacterial infections.
    Oliveira ML; Arêas AP; Ho PL
    Expert Rev Vaccines; 2007 Jun; 6(3):419-29. PubMed ID: 17542756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial crude extracts or ribosomes are recognized similarly by peripheral and mucosal B cells.
    Zanin C; Béné MC; Perruchet AM; Perrin P; Martin F; Borelly J; Faure GC
    FEMS Immunol Med Microbiol; 1994 Nov; 10(1):11-8. PubMed ID: 7874074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhinosinusitis. An overview of current management measures in acute and chronic infection.
    Hadley JA
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):30-6. PubMed ID: 19667547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhinosinusitis: prevention strategies.
    Duse M; Caminiti S; Zicari AM
    Pediatr Allergy Immunol; 2007 Nov; 18 Suppl 18():71-4. PubMed ID: 17767614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of ribosomal fractions of Klebsiella pneumoniae, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and the membrane fraction of Kp (Ribomunyl) in the prevention of clinical recurrences of infectious rhinitis. Results of a multicenter double-blind placebo-controlled study.
    Serrano E; Demanez JP; Morgon A; Chastang C; Van Cauwenberge P
    Eur Arch Otorhinolaryngol; 1997; 254(8):372-5. PubMed ID: 9332892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Emphasis on bacterial vaccines].
    Huet M
    Arch Inst Pasteur Tunis; 1982 Dec; 59(4):481-93. PubMed ID: 6820928
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of new bacterial vaccines in children.
    Klein JO
    Isr J Med Sci; 1983 Nov; 19(11):1026-9. PubMed ID: 6420367
    [No Abstract]   [Full Text] [Related]  

  • 31. [Interferon in the anti-influenza protection provided by a mixtures of bacterial ribosomes and a membrane fraction of K. pneumoniae applied as an aerosol].
    Fontanges R
    Z Erkr Atmungsorgane; 1979 May; 153(2):241-9. PubMed ID: 94959
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative antibacterial activity of cefpodoxime against Haemophilus influenzae, Streptococcus pyogenes, Streptococcus pneumoniae and Moraxella catarrhalis].
    Wallrauch-Schwarz C; Milatovic D; Braveny I
    Arzneimittelforschung; 1994 May; 44(5):668-70. PubMed ID: 8024645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease severity in acute bacterial rhinosinusitis is greater in patients infected with Streptococcus pneumoniae than in those infected with Haemophilus influenzae.
    Benninger M; Brook I; Farrell DJ
    Otolaryngol Head Neck Surg; 2006 Oct; 135(4):523-8. PubMed ID: 17011411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of infections in hyposplenic and asplenic patients: an update.
    Melles DC; de Marie S
    Neth J Med; 2004 Feb; 62(2):45-52. PubMed ID: 15127830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
    Melo-Cristino J; Fernandes ML; Serrano N;
    Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial: Oral bacterial vaccine and colds.
    Lancet; 1974 Dec; 2(7896):1552-3. PubMed ID: 4140987
    [No Abstract]   [Full Text] [Related]  

  • 37. Chemoprophylaxis in asplenic adolescents and young adults.
    Buchanan GR
    Pediatr Infect Dis J; 1993 Oct; 12(10):892-3. PubMed ID: 8284135
    [No Abstract]   [Full Text] [Related]  

  • 38. [Susceptibility to infection after splenectomy for hematologic disease. Is antipneumococcal vaccination and antibiotic prophylaxis needed?].
    Gulías Piñeiro A; Fraguela Mariña J; Fernández Balnco C; Gómez Freijoso C
    Sangre (Barc); 1997 Jun; 42(3):259-60. PubMed ID: 9381281
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinicopathologic study of six cases of meningitis and meningoencephalitis in chimpanzees (Pan troglodytes).
    Solleveld HA; van Zwieten MJ; Heidt PJ; van Eerd PM
    Lab Anim Sci; 1984 Feb; 34(1):86-90. PubMed ID: 6371376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden.
    Kallings I; Bengtsson S; Christensen P; Holm SE; Lind L; Kalin M
    Scand J Infect Dis Suppl; 1983; 39():100-5. PubMed ID: 6359377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.